← Open Payments lookup

AMRINDER DHANOYA: Open Payments

NPI 1255040176 · SAN JOSE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,126 in 93 payments from 17 companies in 2025. Trend: 2023 $1,159 · 2024 $2,442 · 2025 $2,126

Food & beverage: $2,126
CompanyPaymentsAmount
ABBVIE INC.27$434
Amgen Inc.12$263
GlaxoSmithKline, LLC.8$215
Janssen Biotech, Inc.7$214
UCB, Inc.7$181
Radius Health, Inc.6$157
AstraZeneca Pharmaceuticals LP5$145
Aurinia Pharma U.S., Inc.5$121
PFIZER INC.3$95
E.R. Squibb & Sons, L.L.C.3$69

Products named: RINVOQ, BENLYSTA, TREMFYA, Tymlos, Bimzelx, SAPHNELO, LUPKYNIS, XELJANZ.

Industry payments across CA — which companies pay providers there.